TRDA
Entrada Therapeutics Inc
6.20$
-4.3%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| – | – | – | – | +410.7% | +63.4% | -87.9% | |
| – | +213.5% | +242.6% | +69.7% | +5,170.9% | -96.2% | +8.6% | |
| – | – | – | – | – | +63.4% | -89.9% | |
| – | +156.8% | +70.2% | +85.4% | +50.0% | +25.5% | +13.5% | |
| – | +54.2% | +173.2% | +101.6% | +5.4% | +19.1% | +6.7% | |
| – | +122.8% | +94.1% | +90.2% | +35.9% | +23.9% | +8.3% | |
| – | – | – | – | – | – | -431.8% | |
| – | – | – | +8,390.3% | – | – | – | |
| – | – | – | – | – | +451.5% | -314.8% | |
| – | – | – | – | – | -95.4% | +7.6% | |
| – | – | – | – | – | – | -319.0% | |
| – | – | – | – | – | +371.6% | -302.7% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.